Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.
Susan JordanJoan K MorrisGareth I DaviesDavid TuckerDaniel S ThayerJohannes M LuteijnMargery MorganEster GarneAnne V HansenKari KlungsøyrAnders EngelandBreidge BoyleHelen DolkPublished in: PloS one (2016)
The additional absolute risk of teratogenesis associated with SSRIs, if causal, is small. However, the high prevalence of SSRI use augments its public health importance, justifying modifications to preconception care.